BAXALTA
LIVE

Serial Number

79165660

Owner

BAXTER INTERNATIONAL INC.

Attorney

A. Tally Eitan

Filing Date

Feb 25, 2015

Add to watchlist:

No watchlists yet
View on USPTO

BAXALTA Trademark

Serial Number: 79165660 • Registration: 4961987

BAXALTA is a trademark filed by BAXTER INTERNATIONAL INC. on February 25, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

BAXTER INTERNATIONAL INC. (1,146 trademarks)

1430 WAUKEGAN ROAD KB-1A
MC GAW PARK, IL 60085

Entity Type: 03

BAXALTA INCORPORATED (112 trademarks)

BANNOCKBURN, IL 60015

Entity Type: 03

Trademark Details

Filing Date

February 25, 2015

Registration Date

May 24, 2016

Published for Opposition

March 8, 2016

Goods & Services

[Education and training services, namely, providing classes, seminars, conferences, lectures and workshops in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; education services, namely, providing non-downloadable electronic publications in the nature of newsletters and white papers in the field of hemophilia; provision of information for training and teaching relating to pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; provision of non-downloadable electronic publications, namely, newsletters, articles, brochures and booklets in the field of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care]

[Computer software for use in the inputting of patient information for transmission to health care professionals; computer software for use in calculating and tailoring the optimal dosage for patients; computer application software for recording and analyzing patient information; computer application software, namely, software for tracking and managing patients' medication and wellness; computer software for tracking and managing pharmaceutical infusions and physical conditions of patients with bleeding disorders; computer software program for mobile phones, tablets, hand held devices and computers for tracking patient information and providing educational information in the field of hemophilia treatment options, designed for patients and health care professionals; downloadable electronic publications, namely, newsletters, articles, brochures, booklets, white papers and presentations in the field of pharmaceuticals, health care, health insurance, medical information, bleeding conditions, hemophilia, hematology, immunology, oncology and patient care]

[Provision of access to computer databases containing medical information related to hematological, immunological and oncological diseases, disorders and treatment]

Pharmaceutical preparations, substances and products for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceuticals for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceutical preparations, namely, proteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, all containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; immunoglobulin for parenteral, intramuscular and intravenous administration to humans; antihemophilic factor for intravenous administration in humans; antihemophilic factor recombinant; pharmaceutical preparations, namely, chemotherapeutic agents

[Printed publications for teaching, namely, brochures, booklets, training manuals and teaching materials, newsletters and white papers in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding conditions, hemophilia, hematology, immunology, oncology and patient care; printed publications, namely, brochures, booklets, training manuals and teaching materials, newsletters and white papers in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding conditions, hemophilia, hematology, immunology, oncology and patient care; publications, namely, printed instructional and educational guides featuring information about bleeding conditions]

[Medical services and health care; health care services, namely, providing care for human health; medical services, namely, human blood component collection services; medical services, namely, blood purification; medical services, namely, providing medical information in the field of oncology, immunology and hematology via a website; providing an online database for identifying the optimal dosage of medications for patients; medical services, namely, providing free trial prescription service programs for pharmaceutical preparations for the treatment of blood disorders]

Medical devices, namely, devices for reconstituting dried pharmaceuticals; medical apparatus and instruments, namely, medical infusion set for subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parental infusion of pharmaceutical preparations

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 24, 2025 REM4
NEW REPRESENTATIVE AT IB RECEIVED
Feb 28, 2025 NREP
INTERNATIONAL REGISTRATION RENEWED
Dec 12, 2024 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 15, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 30, 2023 INPS
INVALIDATION PROCESSED
Aug 30, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 1, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Dec 1, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Dec 1, 2022 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 7, 2022 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Oct 22, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 21, 2022 NREP
TEAS SECTION 71 RECEIVED
May 23, 2022 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 24, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 8, 2017 FINO
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2016 REAP
FINAL DISPOSITION NOTICE SENT TO IB
Aug 25, 2016 FICS
FINAL DISPOSITION PROCESSED
Aug 25, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
May 24, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2016 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Mar 4, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 17, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 17, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 3, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 15, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 14, 2016 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 11, 2016 GNFN
FINAL REFUSAL E-MAILED
Jan 11, 2016 GNFR
FINAL REFUSAL WRITTEN
Jan 11, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2015 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 19, 2015 CHAN
ASSIGNED TO LIE
Dec 18, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2015 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 1, 2015 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jul 31, 2015 CHLD
REFUSAL PROCESSED BY IB
Jun 27, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 9, 2015 RFCS
REFUSAL PROCESSED BY MPU
Jun 9, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 6, 2015 RFCR
NON-FINAL ACTION WRITTEN
Jun 5, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 5, 2015 MAFR
ASSIGNED TO EXAMINER
Jun 2, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 30, 2015 REPR